Unknown

Dataset Information

0

Diarrheal Etiology and Impact of Coinfections on Rotavirus Vaccine Efficacy Estimates in a Clinical Trial of a Monovalent Human-Bovine (116E) Oral Rotavirus Vaccine, Rotavac, India.


ABSTRACT:

Background

Rotavirus vaccine efficacy (VE) estimates in low-resource settings are lower than in developed countries. We detected coinfections in cases of severe rotavirus diarrhea in a rotavirus VE trial to determine whether these negatively impacted rotavirus VE estimates.

Methods

We performed TaqMan Array Card assays for enteropathogens on stools from rotavirus enzyme immunoassay-positive diarrhea episodes and all severe episodes (Vesikari score ?11), from a phase 3 VE trial of Rotavac, a monovalent human-bovine (116E) rotavirus vaccine, carried out across 3 sites in India. We estimated pathogen-specific etiologies of diarrhea, described associated clinical characteristics, and estimated the impact of coinfections on rotavirus VE using a test-negative design.

Results

A total of 1507 specimens from 1169 infants were tested for the presence of coinfections. Rotavirus was the leading cause of severe diarrhea even among vaccinated children, followed by adenovirus 40/41, Shigella/enteroinvasive Escherichia coli, norovirus GII, sapovirus, and Cryptosporidium species. Bacterial coinfections in rotavirus-positive diarrhea were associated with a longer duration of diarrhea and protozoal coinfections with increased odds of hospitalization. Using the test-negative design, rotavirus VE against severe rotavirus gastroenteritis increased from 49.3% to 60.6% in the absence of coinfections (difference, 11.3%; 95% confidence interval, -10.3% to 30.2%).

Conclusions

While rotavirus was the dominant etiology of severe diarrhea even in vaccinated children, a broad range of other etiologies was identified. Accounting for coinfections led to an 11.3% increase in the VE estimate. Although not statistically significant, an 11.3% decrease in VE due to presence of coinfections would explain an important fraction of the low rotavirus VE in this setting.

SUBMITTER: Praharaj I 

PROVIDER: S-EPMC6603264 | biostudies-literature | 2019 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Diarrheal Etiology and Impact of Coinfections on Rotavirus Vaccine Efficacy Estimates in a Clinical Trial of a Monovalent Human-Bovine (116E) Oral Rotavirus Vaccine, Rotavac, India.

Praharaj Ira I   Platts-Mills James A JA   Taneja Sunita S   Antony Kalpana K   Yuhas Krista K   Flores Jorge J   Cho Iksung I   Bhandari Nita N   Revathy R R   Bavdekar Ashish A   Rongsen-Chandola Temsunaro T   McMurry Timothy T   Houpt Eric R ER   Kang Gagandeep G  

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20190701 2


<h4>Background</h4>Rotavirus vaccine efficacy (VE) estimates in low-resource settings are lower than in developed countries. We detected coinfections in cases of severe rotavirus diarrhea in a rotavirus VE trial to determine whether these negatively impacted rotavirus VE estimates.<h4>Methods</h4>We performed TaqMan Array Card assays for enteropathogens on stools from rotavirus enzyme immunoassay-positive diarrhea episodes and all severe episodes (Vesikari score ≥11), from a phase 3 VE trial of  ...[more]

Similar Datasets

| S-EPMC7738754 | biostudies-literature
| S-EPMC8204902 | biostudies-literature
| S-EPMC4074617 | biostudies-literature
| S-EPMC4532697 | biostudies-literature
| S-EPMC7245145 | biostudies-literature
| S-EPMC6053826 | biostudies-literature
| S-EPMC3761026 | biostudies-literature
| S-EPMC5807168 | biostudies-literature
| S-EPMC4755336 | biostudies-literature
| S-EPMC10052556 | biostudies-literature